Cited by 754Barrier Structure and Function StudiesDrug Transport and Resistance MechanismsExtracellular vesicles in disease

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

The hCMEC/D3 cell line as a model of the human blood brain barrier

Open access

Weksler, Babette, Romero, Ignacio A, Couraud, Pierre-Olivier·2013·Fluids and Barriers of the CNS

DOI 10.1186/2045-8118-10-16PMC PMC3623852

Open this paper in CoChat — free account Open PDF

Abstract

Since the first attempts in the 1970s to isolate cerebral microvessel endothelial cells (CECs) in order to model the blood–brain barrier (BBB) in vitro , the need for a human BBB model that closely mimics the in vivo phenotype and is reproducible and easy to grow, has been widely recognized by cerebrovascular researchers in both academia and industry. While primary human CECs would ideally be the model of choice, the paucity of available fresh human cerebral tissue makes wide-scale studies impractical. The brain microvascular endothelial cell line hCMEC/D3 represents one such model of the human BBB that can be easily grown and is amenable to cellular and molecular studies on pathological and drug transport mechanisms with relevance to the central nervous system (CNS). Indeed, since the development of this cell line in 2005 over 100 studies on different aspects of cerebral endothelial biology and pharmacology have been published. Here we review the suitability of this cell line as a human BBB model for pathogenic and drug transport studies and we critically consider its advantages and limitations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1186/2045-8118-10-16

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line
Weksler, B. B., Subileau, E.-A., Perrière, N., Charneau, P., Holloway, K. E., Leveque, M., Tricoire-Leignel, H., Nicotra, A., Bourdoulous, S., Turowski, P., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3458fje · Cited by 1,325
Self-citation
Wnt/β-catenin signaling controls development of the blood–brain barrier
Liebner, S., Corada, M., Bangsow, T., Babbage, J., Taddei, A., Czupalla, C. J., Reis, M., Felici, A., Wolburg, H., Fruttiger, M., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200806024 · Cited by 860
Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells
Lippmann, E. S., Azarin, S. M., Kay, J. E., Nessler, R. A., Wilson, H. K., Al-Ahmad, A., Palecek, S. P., & Shusta, E. V. (2012) · Nature Biotechnology · doi:10.1038/nbt.2247 · Cited by 800
Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study.
Butt, A. M., Jones, H. C., & Abbott, N. J. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018243 · Cited by 775
Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation
Luissint, A.-C., Artus, C., Glacial, F., Ganeshamoorthy, K., & Couraud, P.-O. (2012) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-9-23 · Cited by 654
Self-citation
ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood–brain barrier
Dauchy, S., Dutheil, F., Weaver, R. J., Chassoux, F., Daumas‐Duport, C., Couraud, P., Scherrmann, J., de Waziers, I., & Declèves, X. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05720.x · Cited by 361
Self-citation
Development of a three-dimensional, all-human in vitro model of the blood–brain barrier using mono-, co-, and tri-cultivation Transwell models
Hatherell, K. E., Couraud, P., Romero, I. A., Weksler, B. B., & Pilkington, G. J. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.05.012 · Cited by 358
Self-citation
The human brain endothelial cell line hCMEC/D3 as a human blood‐brain barrier model for drug transport studies
Poller, B., Gutmann, H., Krähenbühl, S., Weksler, B. B., Romero, I. A., Couraud, P., Tuffin, G., Drewe, J., & Huwyler, J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05730.x · Cited by 318
Self-citation
Differential effects of hydrocortisone and TNFα on tight junction proteins in an in vitro model of the human blood–brain barrier
Förster, C. Y., Burek, M., Romero, I. A., Weksler, B. B., Couraud, P., & Drenckhahn, D. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.146852 · Cited by 306
Self-citation
Immortalized Human Brain Endothelial Cells and Flow-Based Vascular Modeling: A Marriage of Convenience for Rational Neurovascular Studies
Cucullo, L., Couraud, P., Weksler, B. B., Romero, I. A., Hossain, M. K., Rapp, E., & Janigro, D. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600525 · Cited by 266
Self-citation

Show all 77 references

Research works printed but not linked: 1

Lopez-Ramirez MA, Fischer R, Torres-Badillo CC, Davies HA, Logan K, Pfizenmaier K, Male DK, Sharrack B, Romero IA: Role of caspases in cytokine-induced barrier breakdown in human brain endothelial cells. J Immunol. 2012, 189: 3130-3139. 10.4049/jimmunol.1103460. · DOI

Sorted by citations

Items 401–500 of 754

Design, Synthesis, and Preliminary Evaluation of [68Ga]Ga-NOTA-Insulin as a PET Probe in an Alzheimer’s Disease Mouse Model
Taubel, J., Nelson, N. R., Bansal, A., Curran, G. L., Wang, L., Wang, Z., Berg, H. M., Vernon, C. J., Min, H.-K. P., Larson, N. B., et al. (2022) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.2c00126 · Cited by 16
Development of a solvent-free analytical method for paracetamol quantitative determination in Blood Brain Barrier in vitro model
Langlois, M.-H., Vekris, A., Boussès, C., Mordelet, E., Buhannic, N., Séguard, C., Couraud, P., Weksler, B. B., Petry, K. G., & Gaudin, K. (2015) · Journal of Chromatography B · doi:10.1016/j.jchromb.2015.02.019 · Cited by 15
Self-citation
What human blood-brain barrier models can tell us about BBB function and drug discovery?
Ferreira, L. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1646722 · Cited by 15
Rapid integration of screen-printed electrodes into thermoplastic organ-on-a-chip devices for real-time monitoring of trans-endothelial electrical resistance
Kawakita, S., Li, S., Nguyen, H. T., Maity, S., Haghniaz, R., Bahari, J., Yu, N., Mandal, K., Bandaru, P., Mou, L., et al. (2023) · Biomedical Microdevices · doi:10.1007/s10544-023-00669-9 · Cited by 14
Two Signaling Modes Are Better than One: Flux-Independent Signaling by Ionotropic Glutamate Receptors Is Coming of Age
Brunetti, V., Soda, T., Berra‐Romani, R., Sarro, G. D., Guerra, G., Scarpellino, G., & Moccia, F. D. (2024) · Biomedicines · doi:10.3390/biomedicines12040880 · Cited by 14
Bioengineering the neurovascular niche to study the interaction of neural stem cells and endothelial cells
Winkelman, M. A., Koppes, A. N., Koppes, R. A., & Dai, G. (2021) · APL Bioengineering · doi:10.1063/5.0027211 · Cited by 14
Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in Glioblastoma
Joncour, V. L., Guichet, P., Dembélé, K.-P., Mutel, A., Campisi, D., Perzo, N., Desrues, L., Modzelewski, R., Couraud, P., Honnorat, J., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.652544 · Cited by 14
Self-citation
Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Brain Levels of Drug in Rat
Sánchez-Dengra, B., González‐Álvarez, I., Bermejo, M., & González‐Álvarez, M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091402 · Cited by 14
Mistletoe-Based Drugs Work in Synergy with Radio-Chemotherapy in the Treatment of GliomaIn VitroandIn Vivoin Glioblastoma Bearing Mice
Schötterl, S., Miemietz, J. T., Ilina, E. I., Wirsik, N. M., Ehrlich, I., Gall, A., Huber, S. M., Lentzen, H., Mittelbronn, M. G. A., & Naumann, U. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/1376140 · Cited by 14
Liposomes Decorated with 2-(4′-Aminophenyl)benzothiazole Effectively Inhibit Aβ1–42 Fibril Formation and Exhibit in Vitro Brain-Targeting Potential
Mourtas, S., Mavroidi, B., Marazioti, A., Kannavou, M., Sagnou, M., Pelecanou, M., & Antimisiaris, S. G. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00811 · Cited by 14
Substrate Specificity of the Organic Cation Transporters MATE1 and MATE2K and Functional Overlap with OCT1 and OCT2
Redeker, K. M., Kirsch, N., Boretius, S., Tzvetkov, M. V., & Brockmöller, J. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00056 · Cited by 13
Interplay between Systemic Glycemia and Neuroprotective Activity of Resveratrol in Modulating Astrocyte SIRT1 Response to Neuroinflammation
Grabowska, A. D., Wątroba, M., Witkowska, J., Mikulska, A., Sepúlveda, N., & Szukiewicz, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411640 · Cited by 13
A human pluripotent stem cell-derived in vitro model of the blood–brain barrier in cerebral malaria
Gopinadhan, A., Hughes, J. M., Conroy, A. L., John, C. C., Canfield, S. G., & Datta, D. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00541-9 · Cited by 13
Recent advances in 3D models for multiparametric blood–brain barrier detection in microfluidic systems
Boncristiani, C., Gilio, A. D., Castro, F. D., Nardini, A., Palmisani, J., Vàzquez, R. M., de Gennaro, G., Fanizzi, F. P., Ciccarella, G., & Vergaro, V. (2025) · Journal of Materials Chemistry B · doi:10.1039/d4tb02499k · Cited by 14
Valproic Acid-Induced Upregulation of Multidrug Efflux Transporter ABCG2/BCRP via PPARα-Dependent Mechanism in Human Brain Endothelial Cells
Kukal, S., Bora, S., Kanojia, N., Singh, P., Paul, P. R., Rawat, C., Sagar, S., Bhatraju, N. K., Grewal, G. K., Singh, A., et al. (2022) · Molecular Pharmacology · doi:10.1124/molpharm.122.000568 · Cited by 13
Brain endothelial cell expression of SPARCL‐1 is specific to chronic multiple sclerosis lesions and is regulated by inflammatory mediators in vitro
Bridel, C., Simmelink, M. J. A., Peferoen, L. A. N., Troletti, C. D., Durieux, S., Gorter, R. P., Nutma, E., Gami‐Patel, P., Iacobaeus, E., Brundin, L., et al. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12412 · Cited by 13
Model Amphipathic Peptide Coupled with Tacrine to Improve Its Antiproliferative Activity
Silva, S., Alves, C., Duarte, D., Costa, A., Sarmento, B. F. C. C., Almeida, A. J., Gomes, P. A. C., & Vale, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010242 · Cited by 13
Uptake of polymeric nanoparticles in a human induced pluripotent stem cell-based blood–brain barrier model: Impact of size, material, and protein corona
Onyema, H. N., Berger, M., Musyanovych, A., Bantz, C., Maskos, M., & Freese, C. (2021) · Biointerphases · doi:10.1116/6.0000889 · Cited by 12
Aging Increases Hypoxia-Induced Endothelial Permeability and Blood-Brain Barrier Dysfunction by Upregulating Arginase-II
Cheng, X., Potenza, D. M., Brenna, A., Ajalbert, G., Yang, Z., & Ming, X. (2024) · Aging and Disease · doi:10.14336/ad.2023.1225 · Cited by 12
Insulin Signaling Differentially Regulates the Trafficking of Insulin and Amyloid Beta Peptides at the Blood–Brain Barrier
Zhou, A. L., Swaminathan, S. K., Salian, V. S., Wang, L., Curran, G. L., Min, H.-K. P., Lowe, V. J., & Kandimalla, K. K. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00784 · Cited by 12
Human serum albumin-3-amino-1-propanesulfonic acid conjugate inhibits amyloid-β aggregation and mitigates cognitive decline in Alzheimer's disease
Shastri, D., Raorane, C. J., Raj, V., & Lee, S.-K. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.01.019 · Cited by 12
Development and Blood–Brain Barrier Penetration of Nanovesicles Loaded with Cannabidiol
Grifoni, L., Landucci, E., Pieraccini, G., Mazzantini, C., Bergonzi, M. C., Pellegrini-Giampietro, D. E., & Bilia, A. R. (2025) · Pharmaceuticals · doi:10.3390/ph18020160 · Cited by 12
Development of a New Polymeric Nanocarrier Dedicated to Controlled Clozapine Delivery at the Dopamine D2-Serotonin 5-HT1A Heteromers
Łukasiewicz, S. (2021) · Polymers · doi:10.3390/polym13071000 · Cited by 12
Recent advances in cell-based in vitro models for predicting drug permeability across brain, intestinal, and pulmonary barriers
Eltanameli, B., Piñeiro-Llanes, J., & Cristofoletti, R. (2024) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2024.2366390 · Cited by 12
Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish
Joncour, V. L., Karaman, S., & Laakkonen, P. (2019) · Journal of Visualized Experiments · doi:10.3791/59384 · Cited by 10
Three-dimensional co-culture of blood-brain barrier-composing cells in a culture insert with a collagen vitrigel membrane
Shima, A., Nagata, S., & Takeuchi, S. (2020) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-020-00486-x · Cited by 12
In Vivo Imaging of Human MDR1 Transcription in the Brain and Spine of MDR1-Luciferase Reporter Mice
Yasuda, K., Cline, C., Lin, Y. S., Scheib, R., Ganguly, S., Thirumaran, R. K., Chaudhry, A. S., Kim, R. B., & Schuetz, E. G. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.065078 · Cited by 12
Chemical engineering of zein with polyethylene glycol and Angiopep-2 to manufacture a brain-targeted docetaxel nanomedicine for glioblastoma treatment
Awad, S., Araújo, M., Faria, P., Sarmento, B. F. C. C., & Martins, C. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01659-x · Cited by 11
Nanostructured lipid carriers for enhanced batimastat delivery across the blood–brain barrier: an in vitro study for glioblastoma treatment
Horta, M., Soares, P., Sarmento, B. F. C. C., Pereira, C. L., & Lima, R. T. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01775-8 · Cited by 13
In vitro characterization of odorranalectin for peptide-based drug delivery across the blood–brain barrier
Sajja, R. K., Čudić, P., & Cucullo, L. (2019) · BMC Neuroscience · doi:10.1186/s12868-019-0504-x · Cited by 11
Caveolae/rafts protect human cerebral microvascular endothelial cells from Streptococcus suis serotype 2 α-enolase-mediated injury
Jiang, H., Wu, T., Liu, J., Yu, X., Liu, H., Bao, C., Liu, M., Ji, Y., Feng, X., Gu, J., et al. (2021) · Veterinary Microbiology · doi:10.1016/j.vetmic.2021.108981 · Cited by 11
miR-623 Targets Metalloproteinase-1 and Attenuates Extravasation of Brain Metastatic Triple-Negative Breast Cancer Cells
Hammash, D., Mahfood, M., Khoder, G., Ahmed, M., Tlili, A., Hamoudi, R., & Harati, R. (2022) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s372083 · Cited by 11
On-chip real-time impedance monitoring of hiPSC-derived and artificial basement membrane-supported endothelium
Huang, X., Liang, F., Huang, B., Luo, H., Shi, J., Wang, L., Peng, J., & Chen, Y. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115324 · Cited by 11
Amyloid-Beta Peptides 40 and 42 Employ Distinct Molecular Pathways for Cell Entry and Intracellular Transit at the Blood–Brain Barrier Endothelium
Wang, Z., Sharda, N., Omtri, R. S., Li, L., & Kandimalla, K. K. (2023) · Molecular Pharmacology · doi:10.1124/molpharm.123.000670 · Cited by 13
The putative proton-coupled organic cation antiporter is involved in uptake of triptans into human brain capillary endothelial cells
Svane, N., Pedersen, A. B. V., Rodenberg, A., Ozgür, B., Saaby, L., Bundgaard, C., Kristensen, M., Tfelt‐Hansen, P. C., & Brodin, B. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00544-6 · Cited by 11
Interferon-stimulated gene 60 (ISG60) constitutes a negative feedback loop in the downstream of TLR3 signaling in hCMEC/D3 cells
Imaizumi, T., Sassa, N., Kawaguchi, S., Matsumiya, T., Yoshida, H., Seya, K., Shiratori, T., Hirono, K., & Tanaka, H. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.08.016 · Cited by 11
Involvement of NINJ2 Protein in Inflammation and Blood–Brain Barrier Transmigration of Monocytes in Multiple Sclerosis
Sorosina, M., Peroni, S., Mascia, E., Santoro, S., Osiceanu, A. M., Ferrè, L., Clarelli, F., Giordano, A., Cannizzaro, M., Boneschi, F. M., et al. (2022) · Genes · doi:10.3390/genes13111946 · Cited by 10
News from the editors of Fluids and Barriers of the CNS
Drewes, L. R., Jones, H. C., & Keep, R. F. (2014) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-11-13 · Cited by 10
A peptide targeting inflammatory CNS lesions in the EAE rat model of multiple sclerosis
Boiziau, C., Nikolski, M., Mordelet, E., Aussudre, J., Vargas-Sanchez, K., & Petry, K. G. (2018) · Inflammation · doi:10.1007/s10753-018-0748-0 · Cited by 10
Ultrasmall nanoparticles for co-delivery of antisense oligonucleotides targeting miR-21 and miR-210 to treat glioblastoma
Singh, R. R., Kulshreshtha, R., & Popat, A. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03529-1 · Cited by 11
Activation of CB2R by synthetic CB2R agonist, PM289, improves brain endothelial barrier properties, decreases inflammatory response and enhances endothelial repair
Bullock, T. A., Dona, K. N. U. G., Hale, J. F., Morales, P., Jagerovic, N., Andrews, A. M., & Ramirez, S. H. (2023) · NeuroImmune Pharmacology and Therapeutics · doi:10.1515/nipt-2023-0016 · Cited by 10
Molecularly imprinted nanoparticles as drug carriers to the brain
Figueiredo, E. C., Seabra, C. L., Mendes, T. V., Rosa, M. A., Pinho, C. D. L. N., Figueiredo, D. M. D. O., Boralli, V. B., Júnior, M. K. A., de Lima, M. E. T., & Reis, S. (2023) · Journal of Materials Science · doi:10.1007/s10853-023-09053-7 · Cited by 10
Lysosomal TRPML1 triggers global Ca2+ signals and nitric oxide release in human cerebrovascular endothelial cells
Brunetti, V., Berra‐Romani, R., Conca, F., Soda, T., Biella, G. R., Gerbino, A., Moccia, F. D., & Scarpellino, G. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1426783 · Cited by 11
Impact of Tick-Borne Orthoflaviviruses Infection on Compact Human Brain Endothelial Barrier
Schweitzer, F., Letoha, T., Osterhaus, A. D. M. E., & Prajeeth, C. K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052342 · Cited by 10
Unlocking the human blood-brain barrier (BBB) characteristics for the development of nano-delivery strategies for central nervous system therapies
Gokce, C., Altun, B., Kirit, E., Yavuz, H., Uyar, R., Çelik, D., & Yılmazer, A. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106961 · Cited by 12
The non-nutritive sweetener erythritol adversely affects brain microvascular endothelial cell function
Berry, A. R., Ruzzene, S. T., Ostrander, E. I., Wegerson, K. N., Orozco-Fersiva, N. C., Stone, M. F., Valenti, W. B., Izaías, J. E., Holzer, J. P., Greiner, J. J., et al. (2025) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00276.2025 · Cited by 11
The effects of doxorubicin on blood-brain barrier integrity in hCMEC/D3
Patel, C., Glytsou, C., Jang, M.-H., & Cole, P. D. (2025) · NeuroToxicology · doi:10.1016/j.neuro.2025.103355 · Cited by 10
Divergent roles of β‐ and γ‐actin isoforms during spread of vaccinia virus
Marzook, N. B., Latham, S. L., Lynn, H., McKenzie, C., Chaponnier, C., Grau, G. E., & Newsome, T. P. (2017) · Cytoskeleton · doi:10.1002/cm.21356 · Cited by 10
Analysis of L-leucine amino acid transporter species activity and gene expression by human blood brain barrier hCMEC/D3 model reveal potential LAT1, LAT4, B 0 AT2 and y + LAT1 functional cooperation
Taslimifar, M., Faltys, M., Kurtcuoglu, V., Verrey, F., & Makrides, V. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211039593 · Cited by 10
Advances in Biomaterials for Promoting Vascularization
Nelson, R. A., Rhee, E. K., Alaeddine, M. H., & Nikkhah, M. (2022) · Current Stem Cell Reports · doi:10.1007/s40778-022-00217-w · Cited by 10
The Progress in Molecular Transport and Therapeutic Development in Human Blood–Brain Barrier Models in Neurological Disorders
Korszun, J., Krysiak, Z. J., Saluk, J., Niemcewicz, M., & Zdanowski, R. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01473-6 · Cited by 11
In Vivo Approaches to Assessing the Blood–Brain Barrier
Hammarlund‐Udenaes, M. (2013) · Topics in medicinal chemistry · doi:10.1007/7355_2013_27 · Cited by 10
Protective effect of a 3 kDa peptide obtained from beef myofibrillar protein using alkaline-AK on neuronal cells
Lee, S. Y., & Hur, S. J. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.05.003 · Cited by 10
Clostridium perfringens type D epsilon toxin produces a rapid and dose-dependent cytotoxic effect on cerebral microvascular endothelial cells in vitro
Mander, K. A., Uzal, F. A., Williams, R., & Finnie, J. W. (2019) · Journal of Veterinary Diagnostic Investigation · doi:10.1177/1040638719882745 · Cited by 10
Semimechanistic Population Pharmacokinetic Modeling to Investigate Amyloid Beta Trafficking and Accumulation at the BBB Endothelium
Wang, Z., Sharda, N., Curran, G. L., Li, L., Lowe, V. J., & Kandimalla, K. K. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00549 · Cited by 10
Targeting the BspC-vimentin interaction to develop anti-virulence therapies during Group B streptococcal meningitis
Manzer, H. S., Villarreal, R. I., & Doran, K. S. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010397 · Cited by 10
Low molecular weight poly (2-dimethylamino ethylmethacrylate) polymers with controlled positioned fluorescent labeling: Synthesis, characterization and in vitro interaction with human endothelial cells
Flebus, L., Lombart, F., Sevrin, C., Defraigne, J.-O., Péters, P., Parhamifar, L., Molin, D. G. M., & Grandfils, C. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.11.016 · Cited by 10
DNA Subtraction of In Vivo Selected Phage Repertoires for Efficient Peptide Pathology Biomarker Identification in Neuroinflammation Multiple Sclerosis Model
Vargas-Sánchez, K., Vekris, A., & Petry, K. G. (2016) · Biomarker Insights · doi:10.4137/bmi.s32188 · Cited by 10
Dysregulated Sulfide Metabolism in Multiple Sclerosis: Serum and Vascular Endothelial Inflammatory Responses
Veerareddy, P., Dao, N., Yun, J. W., Stokes, K. Y., Disbrow, E. A., Kevil, C. G., Cvek, U., Trutschl, M., Kilgore, P., Ramanathan, M. K., et al. (2022) · Pathophysiology · doi:10.3390/pathophysiology29030044 · Cited by 9
Alzheimer's disease brain endothelial-like cells reveal differential drug transporter expression and modulation by potentially therapeutic focused ultrasound
Chaves, J. C. S., Wasielewska, J. M., Cuní‐López, C., Rantanen, L. M., Lee, S., Koıstınaho, J., White, A. R., & Oikari, L. E. (2023) · Neurotherapeutics · doi:10.1016/j.neurot.2023.10.009 · Cited by 10
Identification of bioaccessible and neuroprotective peptides from fermented casein hydrolysate
Li, R., Shan, S., Xu, Y., Xiong, J., & Cheng, G. (2025) · Journal of Dairy Science · doi:10.3168/jds.2024-25763 · Cited by 9
The expected characteristics of an in vitro human Blood Brain Barrier model derived from cell lines, for studying how ABC transporters influence drug permeability
Puech, C., Delavenne, X., & Perek, N. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.03.002 · Cited by 9
Endothelial cell activation by interleukin-1 and extracellular matrix laminin-10 occurs via the YAP signalling pathway
Thurgur, H., Penny, J., & Pinteaux, E. (2022) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2022.577993 · Cited by 10
Development and evaluation of multi‐functionalized sialic acid conjugated asiatic acid nanoconstruct to mitigate cognitive deficits in Alzheimer's disease
Halder, T., Saha, B., Dhas, N. L., Acharya, S. R., & Acharya, N. S. (2024) · Drug Development Research · doi:10.1002/ddr.22146 · Cited by 9
Temperature Dependence of Membrane Permeability Parameters for Five Cell Types Using Nonideal Thermodynamic Assumptions to Mathematically Model Cryopreservation Protocols
Yadegari, F., Pizarro, L. A. G., Marquez‐Curtis, L. A., & Elliott, J. A. W. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c04534 · Cited by 9
The solute carrier SLC7A1 may act as a protein transporter at the blood-brain barrier
Kurtyka, M., Wessely, F., Bau, S. S., Ifie, E., He, L., de Wit, N. M., Pedersen, A. B. V., Keller, M., Webber, C., de Vries, H. E., et al. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151406 · Cited by 12
Mechanical load increase–induced changes in cytoskeletal structure and cellular barrier function in human cerebral endothelial cells
Kim, D., & Kwon, S. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26742 · Cited by 9
Membrane fusion FerA domains enhance adeno-associated virus vector transduction
Zhang, X., Anthony, B., Chai, Z., Dobbins, A. L., Sutton, R. B., & Li, C. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119906 · Cited by 9
Blood–Brain Barrier Permeability: Is 5-Hydroxytryptamine Receptor Type 4 a Game Changer?
Becker, G., Silva, S. D., Sabo, A.-N., Antal, M. C., Kemmel, V., & Monassier, L. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111856 · Cited by 9
Dysregulation of the Retromer Complex in Brain Endothelial Cells Results in Accumulation of Phosphorylated Tau
Filippone, A., Smith, T., & Praticò, D. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s342096 · Cited by 9
Effect of Withanolide A on 7-Ketocholesterol Induced Cytotoxicity in hCMEC/D3 Brain Endothelial Cells
Soh, S., & Ong, W. (2022) · Cells · doi:10.3390/cells11030457 · Cited by 9
The Blood-Brain Barrier Transport Mechanism Controlling Analgesic Effects of Opioid Drugs in CNS
Okura, T., Higuchi, K., & Deguchi, Y. (2015) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.14-00234-2 · Cited by 9
Shuttle–Cargo Fusion Molecules of Transport Peptides and the hD2/3Receptor Antagonist Fallypride: A Feasible Approach To Preserve Ligand–Receptor Binding?
Wängler, C., Chowdhury, S. F., Höfner, G. C., Djurova, P., Purisima, E. O., Bartenstein, P., Wängler, B., Fricker, G., Wanner, K. T., & Schirrmacher, R. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5004123 · Cited by 9
Cell Culture Models for Drug Transport Studies
Kalashnikova, I. V., Albekairi, N. A., Ali, S., Al-Enazy, S., & Rytting, E. (2016) · Drug Delivery · doi:10.1002/9781118833322.ch7 · Cited by 9
Novel Strategy to Assess the Neurotoxicity of Organic Solvents Such as Glycol Ethers: Protocol for Combining In Vitro and In Silico Methods With Human-Controlled Exposure Experiments
Hopf, N. B., Suter‐Dick, L., Huwyler, J., Borgatta, M., Hegg, L., Pamies, D., Paschoud, H., Puligilla, R. D., Reale, E., Werner, S., et al. (2024) · JMIR Research Protocols · doi:10.2196/50300 · Cited by 8
Antiretroviral drug dolutegravir induces inflammation at the mouse brain barriers
Huang, C., Hoque, M. T., Qu, Q. R., Henderson, J. T., & Bendayan, R. (2024) · The FASEB Journal · doi:10.1096/fj.202400558r · Cited by 8
Dual inhibitors of P-glycoprotein and breast cancer resistance protein for overcoming the blood–brain barrier: in silico discovery and preclinical evaluation
Kang, J., Paik, Y., Ryu, H. J., Lee, J., Shin, I., Park, Y. W., Kim, J., Lim, Y., Shin, H., Kim, W., et al. (2025) · Archives of Pharmacal Research · doi:10.1007/s12272-025-01567-9 · Cited by 8
Novel Ingredients: Hydroxytyrosol as a Neuroprotective Agent; What Is New on the Horizon?
Martínez‐Zamora, L. (2025) · Foods · doi:10.3390/foods14213624 · Cited by 8
Diabetes-related sex differences in the brain endothelin system following ischemia in vivo and in human brain endothelial cells in vitro
Abdul, Y., Li, W., Vargas, J. D., Grant, E., He, L., Jamil, S., & Ergul, A. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0630 · Cited by 8
Relative profiling of L-tryptophan derivatives from selected edible mushrooms as psychoactive nutraceuticals to inhibit P-glycoprotein: a paradigm to contest blood-brain barrier
Margret, A. A., Mareeswari, R., Kumar, K. A., & Jerley, A. A. (2021) · Biotechnologia · doi:10.5114/bta.2021.103762 · Cited by 8
Quantification of In Vitro Blood-Brain Barrier Permeability
Fu, B. M. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1708-3_18 · Cited by 8
Intercellular Calcium Waves and Permeability Change Induced by Vertically Deployed Surface Acoustic Waves in a Human Cerebral Microvascular Endothelial Cell Line (hCMEC/D3) Monolayer
Hsiao, M., Liao, D., Xiang, G., & Zhong, P. (2023) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2022.12.019 · Cited by 8
An automated planar patch-clamp approach to measure the membrane potential and resting membrane currents in a human cerebrovascular endothelial cell line
Soda, T., Negri, S., Scarpellino, G., Berra‐Romani, R., Sarro, G. D., Moccia, F. D., & Brunetti, V. (2024) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2024.110248 · Cited by 8
Mapping the transcriptional and epigenetic landscape of organotypic endothelial diversity in the developing and adult mouse
Gutierrez, M. E. C., Hill, M. C., Largoza, G. E., Gillespie, W. B., Martin, J. F., & Wythe, J. D. (2025) · Nature Cardiovascular Research · doi:10.1038/s44161-025-00618-0 · Cited by 11
Innovative in cellulo method as an alternative to in vivo neurovirulence test for the characterization and quality control of human live Yellow Fever virus vaccines: A pilot study
Costa, A. D., Prehaud, C. J. N., Khou, C., Pardigon, N., Saulnier, A., Nougarede, N., & Lafon, M. (2018) · Biologicals · doi:10.1016/j.biologicals.2018.03.004 · Cited by 7
High-Throughput Screening Assay Identifies Berberine and Mubritinib as Neuroprotection Drugs for Spinal Cord Injury via Blood-Spinal Cord Barrier Protection
Suzuki, Y., Nakagawa, S., Endo, T., Sotome, A., Yuan, R., Asano, T., Otsuguro, S., Maenaka, K., Iwasaki, N., & Kadoya, K. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01310-y · Cited by 8
Syndecan-4 Mediates the Cellular Entry of Adeno-Associated Virus 9
Hudák, A., Roach, M., Pusztai, D., Pettkó‐Szandtner, A., Letoha, A., Szilák, L., Azzouz, M., & Letoha, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043141 · Cited by 8
The Role of Glucose Concentration and Resveratrol in Modulating Neuroinflammatory Cytokines: Insights from an In Vitro Blood–Brain Barrier Model
Komorowska, J., Wątroba, M., Bednarzak, M., Grabowska, A. D., & Szukiewicz, D. (2023) · Medical Science Monitor · doi:10.12659/msm.941044 · Cited by 8
An invertebrate model for CNS drug discovery: Transcriptomic and functional analysis of a mammalian P-glycoprotein ortholog
Al‐Qadi, S., Schiøtt, M., Hansen, S. H., Nielsen, P. A., & Badolo, L. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.09.002 · Cited by 9
In Vitro Models for Studying the Interaction of Neisseria meningitidis with Human Brain Endothelial Cells
Kim, B. J., & Schubert‐Unkmeir, A. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9202-7_10 · Cited by 8
Effects of FTMT Expression by Retinal Pigment Epithelial Cells on Features of Angiogenesis
Buyandelger, U., Walker, D. G., Yanagisawa, D., Morimura, T., & Tooyama, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103635 · Cited by 8
An Induced Pluripotent Stem Cell-Derived Human Blood–Brain Barrier (BBB) Model to Test the Crossing by Adeno-Associated Virus (AAV) Vectors and Antisense Oligonucleotides
Selvakumaran, J., Ursu, S., Bowerman, M., Lu‐Nguyen, N., Wood, M. J. A., Malerba, A., & Yáñez‐Muñoz, R. J. (2023) · Biomedicines · doi:10.3390/biomedicines11102700 · Cited by 7
Pro- and anti-tumour activities of CD146/MCAM in breast cancer result from its heterogeneous expression and association with epithelial to mesenchymal transition
Mannion, A. J., Odell, A. F., Baker, S. M., Matthews, L. C., Jones, P. F., & Cook, G. P. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1129015 · Cited by 7
Evaluating the effect of acute diesel exhaust particle exposure on P-glycoprotein efflux transporter in the blood–brain barrier co-cultured with microglia
Aquino, G. V., Dabi, A., Odom, G., Lavado, R., Nunn, K. L., Thomas, K., Schackmuth, B., Shariff, N., Jarajapu, M., Pluto, M., et al. (2023) · Current Research in Toxicology · doi:10.1016/j.crtox.2023.100107 · Cited by 7
Multi-charged nanoemulsion for photodynamic treatment of glioblastoma cell line in 2D and 3D in vitro models
Borges, H. S., Gusmão, L. A., & Tedesco, A. C. (2023) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2023.103723 · Cited by 7
Protecting the Brain: Novel Strategies for Preventing Breast Cancer Brain Metastases through Selective Estrogen Receptor β Agonists and In Vitro Blood–Brain Barrier Models
Kirchner, J., Völker, E., Shityakov, S., Saji, S., & Förster, C. Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063379 · Cited by 7
Cellular uptake of allicin in the hCMEC/D3 human brain endothelial cells: exploring blood-brain barrier penetration in an in vitro model
Satsantitham, K., Sritangos, P., Wet‐osot, S., Chudapongse, N., & Weeranantanapan, O. (2024) · PeerJ · doi:10.7717/peerj.17742 · Cited by 7
The neuroprotective effect of human umbilical cord MSCs-derived secretome against α-synuclein aggregates on the blood-brain barrier
Marzookian, K., Aliakbari, F., Hourfar, H., Sabouni, F., Otzen, D. E., & Morshedi, D. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140387 · Cited by 7
Transient Receptor Potential Ankyrin 1 (TRPA1) Mediates Hydrogen Sulfide-induced Ca 2+ Entry and Nitric Oxide Production in Human Cerebrovascular Endothelium
Soda, T., Brunetti, V., Sarro, G. D., Biella, G. R., Moccia, F. D., Berra‐Romani, R., & Scarpellino, G. (2025) · Current Neuropharmacology · doi:10.2174/011570159x349872250124124612 · Cited by 7
Review: The potential role of placental extracellular vesicles in blood-brain barrier disruption and neuroinflammation in preeclampsia
Escudero, C., & Vatish, M. (2025) · Placenta · doi:10.1016/j.placenta.2025.04.001 · Cited by 9

Authors: Weksler, B., Romero, I. A., & Couraud, P.-O.
Affiliations: Inserm (FR)
The Open University (GB)
Centre National de la Recherche Scientifique (FR)
Corresponding author: Couraud, Pierre-Olivier
ORCID: Weksler, Babette
Romero, Ignacio A
Venue: Fluids and Barriers of the CNS
Publisher: Springer Science and Business Media LLC
Published: 2013-03-26
Volume: 10
Issue: 1
Pages: 16-16
ISSN: 2045-8118 (ISSN-L)
DOI: 10.1186/2045-8118-10-16
PMC: PMC3623852
OpenAlex: W2115924220
Cited by: 753
References: 77
Citations by year: 2026: 45 · 2025: 70 · 2024: 76 · 2023: 75 · 2022: 68 · 2021: 83 · 2020: 58 · 2019: 63 · 2018: 36 · 2017: 53 · 2016: 42 · 2015: 36 · 2014: 36 · 2013: 10
FWCI: 23.39
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
Locations: Fluids and Barriers of the CNS (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
Open Research Online - ORO (The Open University) (acceptedVersion)
HAL (submittedVersion, other-oa)
Topics: Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Keywords: blood-brain barrier, in vitro BBB model, drug transport across the blood-brain barrier, brain drug delivery, endothelial cell biology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The hCMEC/D3 cell line as a model of the human blood brain barrier

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks